BCYC logo

Bicycle Therapeutics plc (BCYC) EBITDA

annual EBITDA:

-$164.89M+$4.51M(+2.66%)
December 31, 2024

Summary

  • As of today (July 6, 2025), BCYC annual EBITDA is -$164.89 million, with the most recent change of +$4.51 million (+2.66%) on December 31, 2024.
  • During the last 3 years, BCYC annual EBITDA has fallen by -$100.80 million (-157.29%).
  • BCYC annual EBITDA is now -938.30% below its all-time high of -$15.88 million, reached on December 31, 2017.

Performance

BCYC EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBCYCincome statement metrics

quarterly EBITDA:

-$60.16M-$8.98M(-17.54%)
March 31, 2025

Summary

  • As of today (July 6, 2025), BCYC quarterly EBITDA is -$60.16 million, with the most recent change of -$8.98 million (-17.54%) on March 31, 2025.
  • Over the past year, BCYC quarterly EBITDA has dropped by -$35.72 million (-146.20%).
  • BCYC quarterly EBITDA is now -2078.78% below its all-time high of -$2.76 million, reached on March 31, 2018.

Performance

BCYC quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBCYCincome statement metrics

TTM EBITDA:

-$200.61M-$35.72M(-21.66%)
March 31, 2025

Summary

  • As of today (July 6, 2025), BCYC TTM EBITDA is -$200.61 million, with the most recent change of -$35.72 million (-21.66%) on March 31, 2025.
  • Over the past year, BCYC TTM EBITDA has dropped by -$44.10 million (-28.18%).
  • BCYC TTM EBITDA is now -7165.99% below its all-time high of -$2.76 million, reached on March 31, 2018.

Performance

BCYC TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBCYCincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

BCYC EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+2.7%-146.2%-28.2%
3 y3 years-157.3%-124.9%-167.0%
5 y5 years-451.4%-440.7%-381.4%

BCYC EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-157.3%+2.7%-146.2%at low-138.8%at low
5 y5-year-451.4%+2.7%-485.5%at low-381.4%at low
alltimeall time-938.3%+2.7%-2078.8%at low-7166.0%at low

BCYC EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
-$60.16M(+17.5%)
-$200.61M(+21.7%)
Dec 2024
-$164.89M(-2.7%)
-$51.18M(-1.7%)
-$164.89M(+3.0%)
Sep 2024
-
-$52.05M(+39.8%)
-$160.02M(+4.5%)
Jun 2024
-
-$37.23M(+52.4%)
-$153.09M(-2.2%)
Mar 2024
-
-$24.43M(-47.2%)
-$156.51M(-7.6%)
Dec 2023
-$169.40M(+58.0%)
-$46.30M(+2.6%)
-$169.40M(+12.0%)
Sep 2023
-
-$45.12M(+11.0%)
-$151.28M(+14.0%)
Jun 2023
-
-$40.65M(+8.9%)
-$132.66M(+12.6%)
Mar 2023
-
-$37.32M(+32.4%)
-$117.78M(+9.9%)
Dec 2022
-$107.21M(+67.3%)
-$28.19M(+6.3%)
-$107.21M(+11.0%)
Sep 2022
-
-$26.50M(+2.8%)
-$96.58M(+15.0%)
Jun 2022
-
-$25.77M(-3.6%)
-$84.01M(+11.8%)
Mar 2022
-
-$26.74M(+52.3%)
-$75.15M(+17.3%)
Dec 2021
-$64.09M
-$17.56M(+26.0%)
-$64.09M(+1.4%)
Sep 2021
-
-$13.93M(-17.6%)
-$63.23M(+6.1%)
DateAnnualQuarterlyTTM
Jun 2021
-
-$16.91M(+7.8%)
-$59.57M(+9.2%)
Mar 2021
-
-$15.68M(-6.1%)
-$54.56M(+9.1%)
Dec 2020
-$50.00M(+67.2%)
-$16.70M(+62.5%)
-$50.00M(+17.0%)
Sep 2020
-
-$10.27M(-13.7%)
-$42.75M(+2.6%)
Jun 2020
-
-$11.90M(+7.0%)
-$41.68M(+11.0%)
Mar 2020
-
-$11.13M(+17.7%)
-$37.53M(+27.3%)
Dec 2019
-$29.90M(+38.9%)
-$9.45M(+2.7%)
-$29.49M(+5.7%)
Sep 2019
-
-$9.20M(+18.6%)
-$27.89M(+12.1%)
Jun 2019
-
-$7.76M(+151.8%)
-$24.88M(+13.7%)
Mar 2019
-
-$3.08M(-60.8%)
-$21.89M(+1.5%)
Dec 2018
-$21.53M(+35.6%)
-$7.85M(+27.0%)
-$21.57M(+57.3%)
Sep 2018
-
-$6.18M(+29.7%)
-$13.71M(+82.1%)
Jun 2018
-
-$4.77M(+72.7%)
-$7.53M(+172.7%)
Mar 2018
-
-$2.76M
-$2.76M
Dec 2017
-$15.88M
-
-

FAQ

  • What is Bicycle Therapeutics plc annual EBITDA?
  • What is the all time high annual EBITDA for Bicycle Therapeutics plc?
  • What is Bicycle Therapeutics plc annual EBITDA year-on-year change?
  • What is Bicycle Therapeutics plc quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Bicycle Therapeutics plc?
  • What is Bicycle Therapeutics plc quarterly EBITDA year-on-year change?
  • What is Bicycle Therapeutics plc TTM EBITDA?
  • What is the all time high TTM EBITDA for Bicycle Therapeutics plc?
  • What is Bicycle Therapeutics plc TTM EBITDA year-on-year change?

What is Bicycle Therapeutics plc annual EBITDA?

The current annual EBITDA of BCYC is -$164.89M

What is the all time high annual EBITDA for Bicycle Therapeutics plc?

Bicycle Therapeutics plc all-time high annual EBITDA is -$15.88M

What is Bicycle Therapeutics plc annual EBITDA year-on-year change?

Over the past year, BCYC annual EBITDA has changed by +$4.51M (+2.66%)

What is Bicycle Therapeutics plc quarterly EBITDA?

The current quarterly EBITDA of BCYC is -$60.16M

What is the all time high quarterly EBITDA for Bicycle Therapeutics plc?

Bicycle Therapeutics plc all-time high quarterly EBITDA is -$2.76M

What is Bicycle Therapeutics plc quarterly EBITDA year-on-year change?

Over the past year, BCYC quarterly EBITDA has changed by -$35.72M (-146.20%)

What is Bicycle Therapeutics plc TTM EBITDA?

The current TTM EBITDA of BCYC is -$200.61M

What is the all time high TTM EBITDA for Bicycle Therapeutics plc?

Bicycle Therapeutics plc all-time high TTM EBITDA is -$2.76M

What is Bicycle Therapeutics plc TTM EBITDA year-on-year change?

Over the past year, BCYC TTM EBITDA has changed by -$44.10M (-28.18%)
On this page